Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Global Topical Dispenser Market (2020-2025) by Product, Application, End user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Topical Dispenser Market is estimated to be USD 441.38 Mn in 2020 and is expected to reach USD 593.45 Mn by 2025, growing at a CAGR of 6.1%.
Increase in the prevalence of skin infections and diseases and Rising demand for topical applicators is driving the market.
Limited Awareness for the usage of topical dispenser is hindering the market. Preference for alternative modes of drug delivery has created challenges for the market players. Delivery of biologics through the transdermal route and Self-administration and home care have created opportunities for the market.
The Global Topical Dispenser Market is segmented further based on Product, Application, End user and Geography.
By Product, the market is classified into Semi-solid formulations like creams, ointments, lotions, gels and pastes, Liquid formulations like solutions and suspensions, Solid formulations like powders, suppositories and Transdermal products like transdermal patches and transdermal Semi-solids.
By Application, the market is classified into Metered Topical Dispensers and Swab Topical Dispensers. The metered topical dispenser are usually preferred over swab owing to their several benefits, such as optimum efficiency and ease of use.
By End User, the market is classified among Hospitals & Healthcare Providers, Home Care Settings, Burn Centres and other facilities.
By Geography, North America dominated the Topical dispenser market.
1. In August 2019, DoseLogix announced a partnership with B&B Pharmaceuticals, Inc. This partnership will help DoseLogix to increase its product sales in the future.
2. In December 2018, Cipher Pharmaceuticals Inc. (Canada) received acceptance for its "A-101 40% topical solution" for the Health Canada review. This product is prescribed to treat advanced seborrheic keratosis, a commonly occurring non-cancerous skin growth that affects more than 9 million Canadian adults.
3. In December 2018, GlaxoSmithKline (UK) invested USD 36.0 million in manufacturing facilities in Canada to produce and distribute its best topical pain reliever - VOLTAREN.
Some of the companies covered in this report are Johnson and Johnson, Novartis AG, Merck Co., Inc., Bausch Health Companies, Inc., Simcro Limited (Datamars SA), Super Brush LLC, SpecializedRx Products, LLC, BIOSRX, Inc., Volumetric, Inc., Puritan Medical Products Company, LLC, Dose Logix, Porex Corporation, Nestle, etc.
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
The report offers a comprehensive evaluation of the Global Topical Dispenser Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool.
A complete analysis of the market, including parent industry
Important market dynamics and trends
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
Key Topics Covered:
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.4 Years Considered
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
4 Market Overview
4.2 Market Dynamics
184.108.40.206 Increase in the prevalence of skin infections and diseases
220.127.116.11 Rising demand for topical applicators
18.104.22.168 Limited Awareness
22.214.171.124 Delivery of biologics through the transdermal route
126.96.36.199 Self-administration and home care
188.8.131.52 Preference for alternative modes of drug delivery
5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Topical Dispenser Market, By Product
6.1 Semi-Solid Formulations
6.2 Liquid Formulations
6.3 Solid Formulations
6.4 Transdermal Products
6.4.1 Transdermal Patches
6.4.2 Transdermal Semi-solids
7 Global Topical Dispenser Market, By Application
7.2 Metered Topical Dispensers
7.3 Swab Topical Dispensers
8 Global Topical Dispenser Market, By End User
8.2 Home Care Settings
8.3 Hospitals & Clinics
8.4 Burn Centres
8.5 Other Facilities
9 Global Topical Dispenser Market, By Geography
9.2 North America
9.3 South America
9.4.6 Rest of Europe
9.5.6 South Korea
9.5.9 Rest of APAC
9.6 Rest of the World
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 United Arab Emirates
9.6.5 Latin America
10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Mergers & Acquisitions
10.3.2 Agreement, Collaborations, & Partnerships
10.3.3 New Product Launches & Enhancements
10.3.4 Investments & Funding
11 Company Profiles
11.1 Johnson and Johnson
11.2 Novartis AG
11.3 Merck & Co., Inc.
11.4 Bausch Health Companies, Inc.
11.5 Simcro Limited (Datamars SA)
11.6 Super Brush LLC
11.7 SpecializedRx Products, LLC
11.8 BIOSRX, Inc.
11.9 Volumetric, Inc.
11.10 Puritan Medical Products Company, LLC
11.11 Dose Logix
11.12 Porex Corporation
11.14 GlaxoSmithKline plc,
11.15 Bayer AG
11.16 Hisamitsu Pharmaceutical Co. Inc.
11.17 Glenmark Pharmaceuticals
11.19 Crescita Therapeutics
11.20 Mylan N.V.
11.21 Uno Dose
11.22 Fagron Inc.
For more information about this report visit https://www.researchandmarkets.com/r/xgobbt
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900